வாய்வழி மெல்லிய படங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shilpa Medicare fell 3.62% to Rs 498.35 after the company s consolidated net profit slumped 77.35% to Rs 7.83 crore on 5.44% decrease in revenue from operations to Rs 208.03 crore in Q4 March 2021 over Q4 March 2020.
Profit before tax tanked 79.79% to Rs 8.40 crore in Q4 FY21 as against Rs 41.57 crore in Q4 FY20. The Q4 earnings was declared at the fag end of market hours yesterday, 31 May 2021.
EBITDA skid 39% to Rs 33.12 crore in Q4 FY21 as against Rs 54.50 crore over the same period last year. EBITDA margin stood at 15% in Q4 March 2021 from 24% in Q4 March 2020.
During the financial year, Shilpa Medicare s consolidated net profit declined 5.36% to Rs 147.78 crore on 0.75% slip in revenue from operations to Rs 901.13 crore in FY 2021 over FY 2020. ....

Kalpesh Dalal , Vishnukant Bhutada , Shilpa Medicare , Transdermal Dosage Forms , Oral Thin Films , Capital Market , Pharmaceuticals Nec , Oral Thin Films , Biologics Facility , Shilpa Medicare , Managing Director , Chief Financial Officer Cfo , Kalpesh Dalal , Vishnukant Bhutada , விஷ்ணுகாந்த் பூதாடா , ஷில்பா மருத்துவ , வாய்வழி மெல்லிய படங்கள் , மூலதனம் சந்தை , மருந்துகள் கழுத்து ,